Optinose (OPTN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

May22

Paratek Pharmaceuticals Acquires Optinose

15:39

May15

Optinose released FY2025 Q1 earnings on May 14 (EST), actual revenue USD 18.51 M (forecast USD 17.7 M), actual EPS USD -1.9212 (forecast USD -0.74)

03:00

May14

OptiNose Reports Q1 2025 Earnings with Revenue Growth but Expanded Loss

20:13

May8

OptiNose Expected to Report a Quarterly Loss of $0.74 per Share in Q1 2025

13:42

Apr9

Halper Sadeh LLC Investigates Potential Securities Law Violations by Optinose, Inc.

16:54

Mar26

Optinose released FY2024 Q4 earnings on March 26 Pre-Market (EST), actual revenue 22.42 M USD (forecast 20.82 M USD), actual EPS -0.0309 USD (forecast -0.7933 USD)

13:30

Schedules & Filings

Schedules

Filings

May14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 18.51 M, Net Income -22.42 M, EPS -1.9212

Mar26

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 22.42 M, Net Income -360 K, EPS -0.0309

Dec31

Reverse Stock Split(EST)

1-for-15 Reverse Stock Split

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change